Sugawara, Shunichi
Nakagawa, Kazuhiko
Yamamoto, Nobuyuki
Nokihara, Hiroshi
Ohe, Yuichiro
Nishio, Makoto
Takahashi, Toshiaki
Goto, Koichi
Maemondo, Makoto
Ichinose, Yukito
Seto, Takashi
Sakai, Hiroshi
Gemma, Akihiko
Imamura, Fumio
Shingyoji, Masato
Saka, Hideo
Inoue, Akira
Takeda, Koji
Okamoto, Isamu
Kiura, Katsuyuki
Morita, Satoshi
Tamura, Tomohide http://orcid.org/0000-0003-3601-8889
Funding for this research was provided by:
Taiho Pharmaceutical (NA)
Article History
Received: 5 October 2018
Accepted: 30 December 2018
First Online: 4 March 2019
Compliance with ethical standards
:
: Shunichi Sugawara: Taiho (Grant, Honoraria for lecture), Chugai, Pfizer, Nippon Boehringer Ingelheim, AstraZeneca, Eli Lilly, Novartis, Kyowa Hakko Kirin, Bristol-Myers Squibb, Ono, MSD K.K (Honoraria for lecture); Kazuhiko Nakagawa: Taiho, Novartis, Nippon Boehringer Ingelheim, Takeda, Eli Lilly Japan, Eisai, MSD, Ono, Daiichi Sankyo, Chugai, AstraZeneca, Astellas (Grant, Personal fees), Oncotherapy Science, EPS Associates, Quintiles, Japan Clinical Research Operations (Grant); Nobuyuki Yamamoto: Taiho (Grant, Personal fees); Hiroshi Nokihara: Taiho (Grant/Research funding, Honoraria), Boehringer Ingelheim, AstraZeneca, Ono, Eli Lilly, Chugai (Research funding, Honoraria), Merck Serono, Pfizer, Eisai, Novartis, Daiichi Sankyo, GlaxoSmithKline, Yakult, Quintiles, Astellas (Research funding), Sanofi, Bristol-Myers Squibb (Honoraria); Yuichiro Ohe: Taiho, Pfizer, MSD, Novartis (Grant, Honoraria for lecture), AstraZeneca, Chugai, Eli Lilly (Grant, Honoraria for consulting and lecture), Kyorin, Sumitomo Dainippon, Ignita (Grant), Daiichi Sankyo, Nippon Kayaku, Boehringer Ingelheim, Bayer (Honoraria for lecture); Makoto Nishio: Ono, Chugai, Bristol-Myers Squibb, Taiho, Eli Lilly, Pfizer, AstraZeneca (Research funding, Honoraria), Novartis, Astellas (Research funding); Toshiaki Takahashi: Taiho, Takeda, MSD (Grant), AstraZeneca, Eli Lilly Japan, Chugai, Ono (Grant, Personal fees), Boehringer Ingelheim Japan (Personal fees); Koichi Goto: Taiho, Ono, Chugai, Bristol-Myers Squibb, Nippon Boehringer Ingelheim, Pfizer, Kyowa Hakko Kirin, Eli Lilly Japan, Novartis, Daiichi Sankyo, AstraZeneca (Grant, Personal fees), MSD, Quintiles, GlaxoSmithKline, OxOnc, Sumitomo Dainippon, Takeda, Astellas, Eisai, Amgen Astellas BioPharma, Merck Serono, AbbVie Stemcentrx, Riken Genesis (Grant), Yakult, Abbott Japan (Personal fees); Makoto Maemondo: Taiho (Grant); Takashi Seto: Astellas, AstraZeneca, Chugai, Daiichi Sankyo, Eli Lilly Japan, MSD, Nippon Boehringer Ingelheim, Pfizer Japan, Yakult (Grant, Honoraria), Eisai, Merck Serono, Novartis, Verastem (Grant), Bristol-Myers Squibb, Kissei, Kyowa Hakko Kirin, Mochida, Nippon Kayaku, Ono, Roche Singapore, Sanofi, Showa Yakuhin Kako, Taiho, Takeda (Honoraria); Hiroshi Sakai: Bristol-Myers Squibb, Ono, Chugai (Grant); Akihiko Gemma: Taiho (Honoraria for lecture); Fumio Imamura: Taiho, AstraZeneca, Chugai, Ono, MSD, Eli Lilly, Pfizer, Boehringer Ingelheim (Grant, Personal fees); Hideo Saka: Taiho (Grant), AstraZeneca (Research funding, Honoraria), MSD, Eli Lilly Japan, Bristol-Myers Squibb, Sanofi, Chugai, Ono, Bayer (Research funding); Akira Inoue: Taiho (Honoraria for lecture); Koji Takeda: AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Chugai, Eli Lilly, Ono, Taiho, Pfizer (Grant, Personal fees), Merck Serono, Astellas, AbbVie, MSD (Grant), Daiichi Sankyo, Kyowa Hakko Kirin, Novartis (Personal fees); Isamu Okamoto: AstraZeneca, Taiho, Boehringer Ingelheim, Ono, MSD, Eli Lilly, Bristol-Myers Squibb, Chugai (Grant, Personal fees), Astellas, Novartis (Grant), Pfizer (Personal fees); Katsuyuki Kiura: Taiho, Chugai, AstraZeneca (Honoraria, Scholarship donation), Ono, Nippon Boehringer Ingelheim (Research funding, Honoraria, Scholarship donation), Pfizer Japan, Bristol-Myers Squibb, Eli Lilly Japan, Novartis, MSD (Honoraria), Shionogi, Daiichi Sankyo, Nippon Kayaku (Scholarship donation), Roch/Genentech/Chugai (Drug-supply); Satoshi Morita: Taiho (Personal fees); Tomohide Tamura: Taiho, Chugai, Eisai, Yakult, Eli Lilly, Boehringer Ingelheim, Bristol-Myers Squibb, Astellas, Novartis, Ono, Daiichi Sankyo (Honoraria for lecture); Masato Shingyoji: Nothing to disclose.